《中国糖尿病杂志》官方网站

20

您的位置:首页 > 中国糖尿病杂志 > 2011年 > 5期

地特胰岛素用于治疗口服降糖药控制不佳

来自:中国糖尿病资讯网  编辑:huizi|点击数:|2011-10-20

作者单位:408000重庆市涪陵中心医院内分泌科

通讯作者:肖蓉,E-mail:xiaorongtnb@yahoo.com.cn

地特胰岛素用于治疗口服降糖药控制不佳的

2型糖尿病患者疗效观察

周泽华肖蓉

【摘要】目的观察地特胰岛素对口服降糖药(OAD)控制不佳的2型糖尿病(T2DM)患者临床疗效。方法33例OAD血糖控制不佳的T2DM患者,加用地特胰岛素每日睡前皮下注射,共24周。观察用药前后FBG、2hBG、HbA1c、BMI等的变化。结果治疗后T2DM患者FBG、2hBG、HbA1c均明显下降(P<0.01)。日间低血糖发生率9.1%,无夜间症状性低血糖发生,体重无明显增加。结论OAD控制不佳的T2DM患者加用地特胰岛素可有效控制血糖,低血糖发生率低,体重增加不明显。

【关键词】糖尿病,2型;地特胰岛素;口服降糖药

doi:10.3969/j.issn.1006-6187.2011.05.007

Therapeutic effects of insulin detemir on poorly-controlled type 2 diabetes with oral antidiabetic drugs

ZHOU Ze-hua, XIAO Rong. Department of Endocrinology, Peiling Central Hospital of Chongqing city,Chongqing 408000,China

Corresponding author: XIAO Rong,E-mail:xiaorongtnb@yahoo.com.cn

【Abstract】ObjectiveTo investigate the efficacy and safety of insulin detemir in poorly controlled type 2 diabetes (T2DM) with oral antidiabetic drugs. Methods33 cases T2DM patients with inadequate glycemic control were given insulin detemir at bedtime daily on the basis of their oral agents for 24 weeks. FBG, 2h BG, HbA1c and BMI were compared before and after the treatment. ResultsFBG, 2h BG and HbA1c were significantly lower in post-treatment with insulin detemir than in pre-treatment (P<0.01). Incidence of mild hypoglycemia was 9.1%, and there was no symptomatic hypoglycemia. ConclusionInsulin detemir could efficiently inprove diabetes care in poorly controlled T2DM with oral antidiabetic drugs, with a lower incidence of hypoglycemia and no obvious increment of body weight.

【Key words】Diabetes mellitus, type 2;Insulin detemir; Oral antidiabetic drugs

上一篇:新诊断的2型糖尿病患者胰岛素强化治疗前后 下一篇:天芪降糖胶囊对糖耐量减低患者